Back to 
Avoro Capital Advisors LLC
Avoro Capital Advisors LLC
AR2
Showing 0 of 3 quarters
Position history for Avoro Capital Advisors LLC's holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Avoro Capital Advisors held 2,000,000 shares of AR2 (Array Biopharma), worth $92.7M. Avoro Capital Advisors' 13F filings listed AR2 from Q1 2019 to Q2 2019, 2 quarterly filings. AR2 was 3.2% of Avoro Capital Advisors' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.